Advanced search
Publication Cover
Breast Cancer: Targets and Therapy Volume 14, 2022 - Issue
Submit an article Journal homepage
166
Views
0
CrossRef citations to date
0
Altmetric
REVIEW

Advances in Antibody-Drug Conjugates in the Treatment of HER2-Positive Breast Cancer

Yongchao Yu1 Department of Oncology, First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, Tianjin, People’s Republic of China;2 National Clinical Research Center for Chinese Medicine Acupuncture and Moxibustion, Tianjin, People’s Republic of China;3 Tianjin University of Traditional Chinese Medicine, Tianjin, People’s Republic of ChinaORCID Iconhttps://orcid.org/0000-0002-2388-8730
ORCID Icon,
Jin Wang1 Department of Oncology, First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, Tianjin, People’s Republic of China;2 National Clinical Research Center for Chinese Medicine Acupuncture and Moxibustion, Tianjin, People’s Republic of China;3 Tianjin University of Traditional Chinese Medicine, Tianjin, People’s Republic of China
,
Dongying Liao1 Department of Oncology, First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, Tianjin, People’s Republic of China;2 National Clinical Research Center for Chinese Medicine Acupuncture and Moxibustion, Tianjin, People’s Republic of China;3 Tianjin University of Traditional Chinese Medicine, Tianjin, People’s Republic of China
,
Dou Zhang1 Department of Oncology, First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, Tianjin, People’s Republic of China;2 National Clinical Research Center for Chinese Medicine Acupuncture and Moxibustion, Tianjin, People’s Republic of China;3 Tianjin University of Traditional Chinese Medicine, Tianjin, People’s Republic of China
,
Xiaojiang Li1 Department of Oncology, First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, Tianjin, People’s Republic of China;2 National Clinical Research Center for Chinese Medicine Acupuncture and Moxibustion, Tianjin, People’s Republic of China
,
Yingjie Jia1 Department of Oncology, First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, Tianjin, People’s Republic of China;2 National Clinical Research Center for Chinese Medicine Acupuncture and Moxibustion, Tianjin, People’s Republic of China
&
Fanming Kong1 Department of Oncology, First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, Tianjin, People’s Republic of China;2 National Clinical Research Center for Chinese Medicine Acupuncture and Moxibustion, Tianjin, People’s Republic of China;3 Tianjin University of Traditional Chinese Medicine, Tianjin, People’s Republic of ChinaCorrespondence[email protected]
 show all
Pages 417-432 | Received 05 Aug 2022, Accepted 17 Nov 2022, Published online: 04 Dec 2023

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.